MARKET WIRE NEWS

Bayer says Xofigo/Xtandi combo shows overall survival benefit in prostate cancer

Source: SeekingAlpha

2026-02-26 14:36:15 ET

More on Bayer

Read the full article on Seeking Alpha

For further details see:

Bayer says Xofigo/Xtandi combo shows overall survival benefit in prostate cancer
Astellas Pharma Inc

NASDAQ: ALPMF

ALPMF Trading

13.33% G/L:

$15.90 Last:

525 Volume:

$15.90 Open:

mwn-ir Ad 300

ALPMF Latest News

ALPMF Stock Data

$28,999,226,915
1,808,873,137
N/A
N/A
Pharmaceuticals
Healthcare
JP
Chuo-Ku

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App